Literature DB >> 23973821

Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.

Ali A El-Emam1, Abdul-Malek S Al-Tamimi, Mohamed A Al-Omar, Khalid A Alrashood, Elsayed E Habib.   

Abstract

The reaction of 5-(1-adamantyl)-4-substituted-1,2,4-triazoline-3-thione 5a,b and 10a,b with formaldehyde solution and various primary aromatic amines or 1-substituted piperazines yielded the corresponding N-Mannich bases 6a-o, 7a-g and 11a-i. The newly synthesized N-Mannich bases 6a-o, 7a-g and 11a-i were tested for in vitro inhibitory activities against a panel of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. The compounds 6j, 6l, 6m, 7a, 7b, 7c, 7d, 7f, 11a, 11b, 11c, 11d, 11e, 11f, 11h and 11i displayed moderate to good activity against the tested Gram-positive bacteria, while compounds 7c, 11c, 11d, 11f and 11h showed potent broad spectrum antibacterial activity. None of the newly synthesized compounds were proved to possess marked activity against C. albicans.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  1,2,4-triazoles; Adamantane derivatives; Antimicrobial activity; N-Mannich bases

Mesh:

Substances:

Year:  2013        PMID: 23973821     DOI: 10.1016/j.ejmech.2013.07.024

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  15 in total

Review 1.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

2.  3-(Adamantan-1-yl)-1-[(4-benzyl-piperazin-1-yl)meth-yl]-4-ethyl-1H-1,2,4-triazole-5(4H)-thione.

Authors:  Ebtehal S Al-Abdullah; Hanaa M Al-Tuwaijri; Ali A El-Emam; C S Chidan Kumar; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-11-23

3.  Antimicrobial and hypoglycemic activities of novel N-Mannich bases derived from 5-(1-adamantyl)-4-substituted-1,2,4-triazoline-3-thiones.

Authors:  Ebtehal S Al-Abdullah; Hanaa M Al-Tuwaijri; Hanan M Hassan; Mogedda E Haiba; Elsayed E Habib; Ali A El-Emam
Journal:  Int J Mol Sci       Date:  2014-12-11       Impact factor: 5.923

4.  Crystal structure of 3-(adamantan-1-yl)-4-(4-chloro-phen-yl)-1H-1,2,4-triazole-5(4H)-thione.

Authors:  Reem I Al-Wabli; Ali A El-Emam; Obaid S Alroqi; C S Chidan Kumar; Hoong-Kun Fun
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-17

5.  Crystal structure of 2-(adamantan-1-yl)-5-(4-bromo-phen-yl)-1,3,4-oxa-diazole.

Authors:  Nourah Z Alzoman; Ali A El-Emam; Hazem A Ghabbour; C S Chidan Kumar; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-11-05

6.  Syntheses and crystal structures of two adamantyl-substituted 1,2,4-triazole-5-thione N-Mannich bases.

Authors:  Monirah A Al-Alshaikh; Aamal A Al-Mutairi; Hazem A Ghabbour; Ali A El-Emam; Mohammed S M Abdelbaky; Santiago Garcia-Granda
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-07-07

7.  Adamantane-Isothiourea Hybrid Derivatives: Synthesis, Characterization, In Vitro Antimicrobial, and In Vivo Hypoglycemic Activities.

Authors:  Lamya H Al-Wahaibi; Hanan M Hassan; Amal M Abo-Kamar; Hazem A Ghabbour; Ali A El-Emam
Journal:  Molecules       Date:  2017-04-29       Impact factor: 4.411

8.  Synthesis and Bioactivity of Hydrazide-Hydrazones with the 1-Adamantyl-Carbonyl Moiety.

Authors:  Van Hien Pham; Thi Phuong Dung Phan; Dinh Chau Phan; Binh Duong Vu
Journal:  Molecules       Date:  2019-11-05       Impact factor: 4.411

9.  3-(Adamantan-1-yl)-4-ethyl-1-{[4-(2-meth-oxy-phen-yl)piperazin-1-yl]meth-yl}-1H-1,2,4-triazole-5(4H)-thione.

Authors:  Ali A El-Emam; Hanaa M Al-Tuwaijri; Ebtehal S Al-Abdullah; C S Chidan Kumar; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-12-07

10.  Synthesis, antimicrobial, and anti-inflammatory activity, of novel S-substituted and N-substituted 5-(1-adamantyl)-1,2,4-triazole-3-thiols.

Authors:  Ebtehal S Al-Abdullah; Hanadi H Asiri; Siham Lahsasni; Elsayed E Habib; Tarek M Ibrahim; Ali A El-Emam
Journal:  Drug Des Devel Ther       Date:  2014-05-12       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.